Advil Liqui Gels Minis Recalled for Illegible Label Due to Adhesive Migration

Plain-English summary

Glaxosmithkline Consumer Healthcare Holdings (DBA Haleon) is recalling Advil Liqui Gels (minis), which are ibuprofen 200mg liquid-filled capsules marketed as a pain reliever and fever reducer. The recall affects 209,292 capsules distributed nationwide in the United States.

The recall is due to a labeling defect in which adhesive used on the label migrated onto a portion of the label, causing it to tear when peeled back. This results in an illegible label that may not clearly display dosing instructions or other important product information.

The recall applies to the following lot codes: R93517, R94072, and R94073 (expiration date 02/29/2024), and lot code T00655 (expiration date 03/31/2025). Consumers who have purchased affected product should stop using it immediately.

Consumers should discard the affected product or return it to the retailer where it was purchased. For additional information, consumers can contact the FDA or the manufacturer.

The recalled product

Product

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

Manufacturer

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Category

Drug — OTC Pain Reliever

Hazard

• mis-labeling

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Distributed nationwide across the United States.

Related recalls